Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy

Kelly K Hunt; David M Euhus; Judy C Boughey; Anees B Chagpar; Sheldon M Feldman; Nora M Hansen; Swati A Kulkarni; David R McCready; Eleftherios P Mamounas; Lee G Wilke; Kimberly J Van Zee; Monica Morrow

doi:10.1245/s10434-016-5688-z

Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy

Ann Surg Oncol. 2017 Feb;24(2):375-397. doi: 10.1245/s10434-016-5688-z. Epub 2016 Dec 8.

Authors

Affiliations

¹ Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. khunt@mdanderson.org.
² Johns Hopkins University, Baltimore, MD, USA.
³ Mayo Clinic, Rochester, MN, USA.
⁴ Yale University, New Haven, CT, USA.
⁵ Columbia University, New York, NY, USA.
⁶ Northwestern University, Chicago, IL, USA.
⁷ University of Toronto, Toronto, ON, Canada.
⁸ Orlando Health, Orlando, FL, USA.
⁹ University of Wisconsin, Madison, WI, USA.
¹⁰ Memorial Sloan Kettering Cancer Center, New York, NY, USA.

PMID: 27933411
DOI: 10.1245/s10434-016-5688-z

Abstract

Over the past several years, there has been an increasing rate of bilateral prophylactic mastectomy (BPM) and contralateral prophylactic mastectomy (CPM) surgeries. Since publication of the 2007 SSO position statement on the use of risk-reducing mastectomy, there have been significant advances in the understanding of breast cancer biology and treatment. The purpose of this manuscript is to review the current literature as a resource to facilitate a shared and informed decision-making process regarding the use of risk-reducing mastectomy.

Publication types

Review

MeSH terms

Breast Neoplasms / surgery*
Decision Making*
Female
Humans
Mastectomy*
Neoplasms, Second Primary / prevention & control*
Prognosis
Risk Reduction Behavior*
Societies, Medical
Surgical Oncology*